in vivo CAR-T drug based on LNP-mRNA
Sponsors
Xinqiao Hospital of Chongqing
Conditions
Autoimmune DiseasesB-cell Malignancies
Early Phase 1
Exploratory Study on mRNA Therapeutic Drug Targeting CD19 for the Treatment of Hematologic Malignancies
RecruitingNCT07349849
Start: 2025-12-20End: 2028-12-31Target: 47Updated: 2026-01-20
Exploratory Study on mRNA Therapy Targeting CD19 for the Treatment of Refractory Autoimmune Diseases
Not yet recruitingNCT07362758
Start: 2026-01-01End: 2028-12-31Target: 47Updated: 2026-01-23